Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines

Mizuho Tanabe1, Hiroto Izumi, Tomoko Ise

  • 1Departments of Molecular Biology and. Surgery II, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Fukuoka, Japan.

Cancer Research
|December 26, 2003
PubMed

Insights

Activating transcription factor 4 (ATF4) expression correlates with cisplatin sensitivity in lung cancer. Higher ATF4 levels may predict reduced sensitivity to cisplatin chemotherapy, aiding treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Cisplatin resistance is a significant challenge in solid tumor treatment.
  • Identifying molecular determinants of cisplatin resistance is crucial for improving therapeutic outcomes.

Purpose of the Study:

  • To identify genes involved in cisplatin resistance.
  • To investigate the role of activating transcription factor 4 (ATF4) in cisplatin sensitivity.

Main Methods:

  • Differential display of mRNA to identify cisplatin-inducible genes.
  • Northern blot analysis to assess ATF4 expression.
  • Correlation analysis of ATF4 levels with cisplatin sensitivity in 11 human lung cancer cell lines.
  • Overexpression studies in stable transfectants.

Main Results:

  • Activating transcription factor 4 (ATF4) was identified as a cisplatin-inducible gene.
  • ATF4 expression is transcriptionally regulated and upregulated in cisplatin-resistant cell lines.
  • ATF4 expression levels significantly correlated with cisplatin sensitivity (P = 0.01).
  • Overexpression of ATF4 reduced sensitivity to cisplatin but not vincristine.

Conclusions:

  • Cellular levels of ATF4 are linked to cisplatin sensitivity.
  • ATF4 expression may serve as a predictive biomarker for cisplatin response in lung cancer.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...